Journal Collaborations & Media Partners
The Formulation & Delivery Series US marketing team work with leading journal publications on reciprocal marketing arrangements.
If you are interested in promoting your journal/association to the leading players in this industry please contact us.
ONdrugDelivery is the topic-specific publication that focuses tightly on one area within the field of drug delivery in each issue. Topics include Novel Oral Delivery Systems, Connecting Drug Delivery, Pulmonary & Nasal, Industrialisation, Skin Drug Delivery: Dermal, Transdermal & Microneedles, and PFS & Injection Devices. Established for 15 years, with a global readership and high quality, insightful contributions from leading experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. We know drug delivery.
Pharmaceuticals (ISSN 1424-8247) is an open accessed, PubMed , Scopus and ESCI indexed journal of medicinal chemistry and related drug sciences, published quarterly online by MDPI. CiteScore is 3.80, which equals rank 23/164 (Q1) in 'Pharmaceutical Science' and rank 39/165 (Q1) in 'Molecular Medicine'. Manuscripts are peer-reviewed and a first decision provided to authors approximately 16 days after submission; acceptance to publication is undertaken in 5.6 days. (median values for papers published in this journal in the second half of 2018).
PHARMAnetwork is a company specialized in publishing for the pharmaceutical industry. PHARMAnetwork has developed publications for CMO, CDMO and professionals working in the life sciences. PHARMAnetwork designs specialized studies for pharmaceutical companies, contract service providers and investment firms. PHARMAnetwork magazine covers, every aspect of pharmaceutical value chain, the change and developments in the intersection between pharmaceutical industry and outsourcing industry. We perform interviews and write articles whose thematic strategies, organizations, mergers and acquisitions, regulatory, innovation in the pharmaceutical development and contract manufacturing.
MedTech Outlook is a superlative podium for suppliers to showcase their products and services and healthcare industry professionals to connect with a global audience of decision-makers. Its unique learn-from-peer approach creates an immense impact in the U.S. market, adding a big difference in this continuously evolving medical tech arena.
pharmaphorum media was launched with the mission being to help all healthcare stakeholders communicate, connect and collaborate in order to drive medical innovation and deliver better outcomes for patients, with the pharmaceutical industry being at the core of this.
Medical Sciences (ISSN 2076-3271) is an international open access scientific journal, providing a platform for advances in basic, translational and clinical research. The journal aims to publish original research, review articles and short communications about molecular and cellular processes in disease, in order to increase understanding of the fundamental principles and biological questions of medicine. Researchers in academic and clinical settings as well as health professionals are encouraged to publish their theoretical and experimental results in this journal, which aims to integrate expertise from the molecular and translational sciences, therapeutics, and diagnostics in different medical specialties.
The “International Journal of Pharma and Bio Sciences” (IJPBS) is an international online journal in English published quarterly. The aim of IJPBS is to publish peer reviewed research and review articles in rapidly developing field of pharmaceutical and biological sciences. This journal is an online journal having full access to the research and review paper. The journal aims to cover the latest outstanding developments in the field of pharmaceutical and biological sciences.
The “International Journal of Life science and Pharma Research” (IJLPR) is an international journal in English published online quarterly. Aim of IJLPR is to publish peer reviewed review and research articles in rapidly developing field of Pharma and life sciences. This journal is an online journal having full access to the published review and research papers. The journal aims to cover the latest outstanding developments in the field of life science and Pharmaceutical sciences specifically in their respective branches.
PharmaVision offers a consultancy service providing high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies. The research reports combine in-depth interviews with key opinion leaders, scientific analysis with market models to forecast the potential growth of key developmental products and technologies, identify marker drivers/resistors and identify unique selling features to guide product development
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.